Celltrion Wins Brazilian Trastuzumab and Rituximab Tender
As Company Aims to Lead Latin American Biosimilar Market
• By Akriti Seth
Celltrion has won the Brazilian contract for anticancer therapeutics for the second year in a row • Source: Alamy (Alamy Stock Photo) 
